Australia markets open in 8 hours 2 minutes

Envoy Medical, Inc. (COCHW)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.0819+0.0179 (+28.32%)
As of 11:54AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0640
Open0.0792
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0792 - 0.0968
52-week range0.0792 - 0.0968
Volume13,732
Avg. volumeN/A
Market capN/A
Beta (5Y monthly)2.58
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Envoy Medical to Present at the Planet MicroCap Showcase: Vegas 2024

    WHITE BEAR LAKE, Minnesota, April 24, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV. Presentation Date: May 1, 2024 Time: 8:30am Pacific Time

  • GlobeNewswire

    Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

    WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024. The conference is being held on April 8 - 9, 2024 at the Sofitel Hotel in New York City. Presentation Date: Tuesday, Apri

  • GlobeNewswire

    Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

    Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones Recent bipartisan Congressional bill, the Hearing Device Coverage Clarification Act, seeks to open a pathway to insurance coverage for the Company's Esteem® Fully Implanted Active Middle Ear Implant WHITE BEAR LAKE, Minn., April 02, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hear